Hugo RAS系统辅助右半结肠癌根治术早期实施可行性的倾向性评分匹配探索性研究
本研究为双中心回顾性队列研究,纳入2019年9月至2025年4月接受机器人辅助右半结肠切除术(RARC)联合完整结肠系膜切除的74例右侧结肠癌患者,经1:1倾向性评分匹配后比较Hugo组与da Vinci组各22例的围术期、术后及病理结局。结果显示Hugo组总手术时间显著更长(286 vs 246 min;P=0.015),但控制台时间、估计出血量、病理结局及术后住院时间组间可比,两组均无中转开腹、吻合口漏、再手术、30天再入院或死亡。结论认为Hugo系统早期实施RARC可行且短期结局可接受,但需进一步多中心前瞻性研究验证。
要点
- Hugo组总手术时间显著长于da Vinci组(286 vs 246 min;P=0.015)。
- 两组病理结局(切缘、淋巴结检出数)及术后住院时间相似。
- 两组均无中转开腹、吻合口漏、再手术、30天再入院或死亡。
核心结论
- Hugo RAS系统辅助右半结肠癌根治术早期实施可行,短期围术期及病理结局可接受。
- Hugo组总手术时间较da Vinci组长,但其他短期结局大致相似,应视为初步结果。
研究设计与样本
- 双中心回顾性队列研究,纳入2019年9月至2025年4月接受RARC联合完整结肠系膜切除的右侧结肠癌患者74例。
- 排除因非结直肠疾病行多脏器切除或合并多原发结直肠癌者,采用1:1倾向性评分匹配后比较Hugo组与da Vinci组各22例。
主要发现
- 匹配后基线特征更均衡,但仍存在轻度不平衡。
- 控制台时间(146 vs 132 min;P=0.549)和估计出血量(5 vs 0 mL;P=0.299)组间可比。
- Hugo组总手术时间显著更长(286 vs 246 min;P=0.015)。
- 病理结局包括切缘和淋巴结检出数组间相似。
- 两组均无中转开腹、吻合口漏、再手术、30天再入院或死亡;da Vinci组发生1例与手术无关的Clavien-Dindo IIIa级并发症。
临床怎么用
- 在有限匹配队列中,Hugo系统可用于右侧结肠癌机器人辅助右半结肠切除术的早期实施。
- 需注意Hugo系统可能延长总手术时间,其他短期结局与da Vinci系统大致相似。
局限性
- 样本量有限,为回顾性研究,匹配后仍存在轻度基线不平衡。
- 结果为初步短期结局,需多中心前瞻性研究验证并评估长期肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical evidence for robot-assisted right colectomy (RARC) using the Hugo RAS system remains limited. We aimed to describe the early implementation experience of Hugo-assisted RARC and to preliminarily compare short-term outcomes with those of the da Vinci system. METHODS: This dual-center retrospective cohort study included 74 patients who underwent RARC with complete mesocolic excision for right-sided colon cancer between September 2019 and April 2025. Patients who underwent multivisceral resections for non-colorectal disease or had multiple colorectal cancers were excluded. Propensity score matching (PSM) was applied at a 1:1 ratio, and the perioperative, postoperative, and pathological outcomes of 22 patients in each group treated using Hugo or da Vinci system were compared. RESULTS: The baseline characteristics were more balanced after matching, although a slight imbalance remained. The console time (146 vs. 132 min; P = 0.549) and estimated blood loss (5 vs. 0 mL; P = 0.299) were comparable, but the total surgical duration was significantly longer for the Hugo group (286 vs. 246 min; P = 0.015). The pathological outcomes, including resection margins and harvested lymph nodes, were similar between groups. No conversion to open surgery, anastomotic leakage, reoperation, 30-day readmission, or mortality occurred in either group. One Clavien-Dindo grade IIIa complication unrelated to the surgery occurred in the da Vinci group. The postoperative hospital stay was comparable between the groups. CONCLUSIONS: The early implementation of RARC using Hugo appeared feasible and yielded acceptable short-term perioperative and pathological outcomes in a limited matched cohort. Although the total surgical duration was longer with the Hugo RAS system than with the da Vinci system, other short-term outcomes were broadly similar between the groups and should be interpreted as preliminary. Further multicenter prospective studies are needed to validate these findings and evaluate long-term oncological outcomes.
引用
- Hiramatsu K, Toda S, Matoba S, et al. Early implementation and feasibility of Hugo RAS system-assisted right colectomy for right-sided colon cancer: an exploratory propensity score-matched comparison with the da Vinci surgical system. Surg Endosc. 2026. PMID: 42754633. doi:10.1007/s00464-026-13344-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。